3 completed, 1 recruiting. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Other Specified Pulmonary Tuberculosis: new trials by email Literature Review of Other Specified Pulmonary Tuberculosis trials Research Report on Other Specified Pulmonary Tuberculosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BTZ-043 Dose Evaluation in Combination and Selection BTZ-043, Bedaquiline, Delamanid - Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis | Phase 2 | Completed | Michael Hoelscher | 92 | 2023-09-21 | 2026-10-05 |
| PanACEA - STEP2C -01 BTZ-043, Rifampicin, Isoniazid - Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis | Phase 2 | Recruiting | Michael Hoelscher | 390 | 2023-04-14 | 2025-10-07 |
| PanACEA Sutezolid Dose-finding and Combination Evaluation Sutezolid, Bedaquiline, Delamanid, Moxifloxacin, Midazolam oral solution - Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis | Phase 2 | Completed | Michael Hoelscher | 75 | 2021-05-06 | 2023-05-01 |
| BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA) BTZ-043, Rifafour e-275®, Probe Drug Cocktail - Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis | Phase 1 / Phase 2 | Completed | Michael Hoelscher | 78 | 2019-11-15 | 2026-08-31 |
Tuberculosis (4) · Tuberculosis, Pulmonary (4) · Gram-Positive Bacterial Infections (2)
Actinomycetales Infections (4) · Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Infections (4) · Lung Diseases (4) · Mycobacterium Infections (4) · Respiratory Tract Diseases (4) · Respiratory Tract Infections (4) · Gram-Positive Bacterial Infections (2)
2-(2-methyl-1,4-dioxa-8-azaspiro(4.5)dec-8-yl)-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one (3) · Moxifloxacin (3) · Ethambutol (2) · Isoniazid (2) · OPC-67683 (2) · Pyrazinamide (2) · Rifampin (2) · bedaquiline (2) · Ethionamide (1) · GSK656 (1) · Midazolam (1) · PNU-100480 (1) · delpazolid (1) · dolutegravir (1) · pretomanid (1)
South Africa (4) · Tanzania (3) · Gabon (1) · Malawi (1) · Mozambique (1) · Uganda (1)
Andreas Diacon, Prof (1) · Michael Hoelscher, Prof (1) · Michael Hoelscher, Prof Dr (1) · Michael Hoelscher, Prof Dr. (1) · Michael Hoelscher, Prof. (1)